Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quyuan Sunnycare is a China-based manufacturing subsidiary within the Sunnycare group focused on producing nutraceutical and health-related ingredients rather than developing a therapeutic drug pipeline. The company manufactures microalgae DHA oil and powder, plant extracts, pharmaceutical intermediates, herbal active components, and other natural ingredients used in dietary supplements, food and beverage, cosmetics, animal nutrition, and some pharmaceutical applications. Its operations appear to center on GMP-standard production, ingredient extraction, purification, quality testing, and global export supply. Available public information indicates Quyuan Sunnycare functions primarily as a commercial manufacturing site established in Hunan, China, supporting the broader Sunnycare organization led by Changsha Sunnycare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quyuan Sunnycare.